Prognostic indicators for poor risk epithelial ovarian carcinoma

Area of Science:

• Gynecologic Oncology
• Clinical Chemistry
• Cancer Prognostics

Background:

• Epithelial ovarian carcinoma (EOC) prognosis is complex.
• Identifying prognostic factors at initial treatment is crucial for patient stratification.

Purpose of the Study:

• To identify factors that categorize EOC patients into favorable and unfavorable prognostic groups.
• To refine prognostic assessment beyond initial surgical outcomes.

Main Methods:

• Analysis of data from 51 women with EOC treated at Yale University.
• Evaluation of evaluable CA 125 half-life (t1/2) and disease recurrence over at least 2 years.
• Assessment of prognostic value of stage, residual disease, minimum CA 125, and CA 125 t1/2.

Main Results:

• Stage, residual disease, minimum CA 125, and CA 125 t1/2 were individually predictive of recurrence.
• A combined model using residual disease (>1 cm), CA 125 t1/2 (>12 days), or minimum CA 125 (>35 U/ml) showed high sensitivity and specificity for predicting persistent disease or recurrence.
• This combined model achieved 91% sensitivity and 75% specificity at 3 years.

Conclusions:

• Minimum CA 125 and CA 125 t1/2 during chemotherapy are valuable for prognostic categorization in EOC.
• These markers further stratify patients with good prognosis based on minimal residual disease after surgery.
• Refined prognostic assessment aids in treatment planning and patient management for EOC.